Trial intelligence / Profile preview

Centella asiatica for pain and wound healing in second-degree burns

IRCT20181229042166N1Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Feb 2019
Countries
1
01

Overview

Phase 3 trial of centella asiatica in burn injury, sponsored by Arak University of Medical Sciences. Primary endpoints: Pain reduction and Wound healing. Started Feb 2019; status: completed.

02

Drugs

centella asiatica
03

Conditions

burn injury

Beyond the preview

Go deeper on IRCT20181229042166N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181229042166N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call